Browse Tag


Anti-cancer drug derived from fungus shows promise in clinical trials

4 mins read

The FINANCIAL — A new industry-academic partnership between the University of Oxford and biopharmaceutical company NuCana as found that chemotherapy drug NUC-7738, derived from a Himalayan fungus, has 40 times greater potency for killing cancer cells than its parent compound.…

Roche and Atea Pharmaceuticals partner to develop potential oral treatment for coronavirus patients

4 mins read

The FINANCIAL — Roche and Atea Pharmaceuticals, Inc. announced today that they are joining forces in the fight against COVID-19 to develop, manufacture and distribute AT-527, Atea’s investigational oral direct-acting antiviral, to people around the globe. AT-527 acts by blocking the viral RNA polymerase enzyme needed for viral replication, and is currently being studied in…